tirzepatide glp 1 side effects Exploring the of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning TrimRX | Tirzepatide Side Effects:

The authors of this paper use several graphing techniques to present their data

The incidence of MACE in patients with and without established CV disease was 13.4% in the BYDUREON group versus 14.6% in the placebo group and 6.0% (BYDUREON) versus 5.9% (placebo), respectively

Their results did not indicate major differences in risk of non-live birth, abnormal fetal growth, or major congenital malformations with continuation of dispensing into pregnancy (at least 1 further dispensation) relative to non-continuation

Park HJ, Jung E, Shim I

GLP-1 therapies go beyond weight lossImprove liver fat and inflammation by reducing nutrient flux to the liver - Enhance insulin sensitivity in adipose tissue - May have anti-inflammatory effects independent of weight loss 3

Relationship between GLP-1 and cardiovascular diseases Recent studies have shown that GLP-1R has a role in signal transduction and intracellular metabolism, and that it is highly expressed in human cardiovascular cells